Amgen Inc
(HKSE:04332)
HK$
1761
0 (0%)
Market Cap: 1.17 Til
Enterprise Value: 1.57 Til
PE Ratio: 35.86
PB Ratio: 20.00
GF Score: 92/100 Amgen Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2020 / 06:50PM GMT
Release Date Price:
HK$1850
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Fantastic. Listen, thank you guys for joining us. I think it's become a bit of a custom now hosting Amgen Management on our conference. Pleasure to have the whole team. We have David from the R&D side. We have Peter from the finance office. We have Arvind from the Investor Relations and the finance office. So really great to see everyone.
Arvind, I'll turn it over to you for some opening comments. And at the end of the opening comments, Arvind, can you also tell us how many books are behind David?
Arvind Sood
Amgen Inc. - VP of IR
Well, let me actually start off with that. I think he's got about 80 books back there. And he has read all of them.
Umer Raffat;David M. Reese
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research;Amgen Inc. - EVP of Research &
Okay. No, he's wearing all of them.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot